ODDB.org: Open Drug Database

Irinotecan Fresenius 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung -

Swissmedic Key	61246017	Registration Holder	Fresenius Kabi (Schweiz) AG
Name	Irinotecan Fresenius 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung	Date of registration	28.01.2011
Original/Generic	Generic	Introduction of Sequence	28.01.2011
ATC-Classification	Irinotecan (L01XX19)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.10.	Show package size
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	37.83	Limitation	No

Deductible	10 %	Consumer price	57.55
Feedback	FB
GTIN	7680612460176	Medication Code	Synthetika
Pharmacode	7738398	Disponibility

Composition

irinotecani hydrochloridum trihydricum 40 mg, sorbitolum 90 mg, acidum lacticum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 2 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	40mg / 2ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	40 mg

Inactive agents	Dose
Acidum Hydrochloridum ad Ph
Lactic Acid
Natrii Hydroxidum ad Ph
Sorbitol	90mg / 2ml

Source

Data was imported : 11.07.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH